Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.
about
Blood transcriptomics and metabolomics for personalized medicineGlobally Optimized Targeted Mass Spectrometry: Reliable Metabolomics Analysis with Broad CoverageMetabolic characterization of invaded cells of the pancreatic cancer cell line, PANC-1.Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.Long term conservation of human metabolic phenotypes and link to heritability.Metabolomics identifies the intersection of phosphoethanolamine with menaquinone-triggered apoptosis in an in vitro model of leukemiaPerioperative dynamics and significance of amino acid profiles in patients with cancer.Metabolic signatures differentiate ovarian from colon cancer cell lines.Urine metabolomic profiling of children with respiratory tract infections in the emergency department: a pilot studyExperimental design and reporting standards for metabolomics studies of mammalian cell lines.Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.Programmed cell death in periodontitis: recent advances and future perspectives.Lessons learned and challenges posed in cancer genetics. Introduction.Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells.Monitoring for Response to Antineoplastic Drugs: The Potential of a Metabolomic Approach.Metabolomics toward personalized medicine.Change of the metabolomic profile during short-term mononuclear cell storage.IntLIM: integration using linear models of metabolomics and gene expression data.Optimisation of in vitro sample preparation for LC-MS metabolomics applications on HepaRG cell culturesUrea influences amino acid turnover in bovine cumulus-oocyte complexes, cumulus cells and denuded oocytes, and affects in vitro fertilization outcome
P2860
Q26772073-E699A2C8-6058-42B0-88B1-2B55B067D5FDQ33707386-67A1EB1C-72F2-402A-89FB-CA711E6F3479Q33738817-AFC6DC3A-569D-47B5-B871-7468D9030E09Q33745104-689405EA-E04D-4CF6-96D5-39F1CDC0BF5FQ34091261-0D064489-28F9-4F3D-B78F-D4C904B2A2A0Q34671698-2851F8D5-5E7D-4A77-AE52-6678DEE8B2D5Q35096373-0D1C2056-7EDE-4057-9D39-B6E9AB906AF5Q35844833-D33FC997-33F9-4735-AA2B-57B6BFCD7117Q36109560-51DB3B46-7B12-47C8-AA46-0F0DBF6B9E4DQ38698193-73E86BFD-4328-44D4-82BD-A386E281A0E1Q38787802-D6058470-073B-48F4-AE39-45C8F0264B0EQ38826371-ACEF62C3-63AF-4461-9250-7387F1106E36Q44539143-74C2638D-B667-47DE-92BF-308482A9D26AQ47106277-5CFE6EE5-6457-4E86-9A92-EFA6FA5F56EEQ47111053-AC2366F9-4A22-4239-B376-15A5FC063409Q50090010-0233270F-7B0F-48B1-A824-1B7A32324E80Q50973215-993A39A4-CEB2-4D9A-BA0E-FE198FCC8DDCQ52366931-AF74FC62-AD79-4E22-AB03-FA225D219ECCQ57523698-DCC40001-624E-4B38-B5CD-ABBB0972EAFFQ58778499-BDD56409-05B1-47F5-9DB7-B1FF7100545A
P2860
Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Identification of biomarkers f ...... s for individualized medicine.
@en
Identification of biomarkers f ...... s for individualized medicine.
@nl
type
label
Identification of biomarkers f ...... s for individualized medicine.
@en
Identification of biomarkers f ...... s for individualized medicine.
@nl
prefLabel
Identification of biomarkers f ...... s for individualized medicine.
@en
Identification of biomarkers f ...... s for individualized medicine.
@nl
P2860
P50
P356
P1476
Identification of biomarkers f ...... s for individualized medicine.
@en
P2093
P2860
P304
P356
10.1111/JOIM.12117
P407
P577
2013-11-01T00:00:00Z